Aurora Cannabis 将来の成長

Future 基準チェック /16

Aurora Cannabisは、154.3%と11.8%でそれぞれ年率154.3%で利益と収益が成長すると予測される一方、EPSはgrowで74.9%年率。

主要情報

154.3%

収益成長率

74.9%

EPS成長率

Pharmaceuticals 収益成長	53.6%
収益成長率	11.8%
将来の株主資本利益率	n/a
アナリストカバレッジ	Low
最終更新日	08 Nov 2024

今後の成長に関する最新情報

Recent updates

Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump

Nov 22

It's Unlikely That Aurora Cannabis Inc.'s (TSE:ACB) CEO Will See A Huge Pay Rise This Year

Aug 02

Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump

Jun 27

Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term

Nov 13

Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?

Sep 22

Aurora Cannabis (TSE:ACB) Is Carrying A Fair Bit Of Debt

Apr 21

業績と収益の成長予測

TSX:ACB - アナリストの将来予測と過去の財務データ ( )CAD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	392	N/A	N/A	N/A	1
3/31/2026	360	8	15	40	3
3/31/2025	329	-9	-3	-14	5
9/30/2024	297	-30	-61	-43	N/A
6/30/2024	279	-30	-67	-49	N/A
3/31/2024	270	-55	-85	-69	N/A
12/31/2023	266	-116	-91	-71	N/A
9/30/2023	262	-153	-145	-127	N/A
6/30/2023	248	-195	-141	-127	N/A
3/31/2023	224	-793	-163	-142	N/A
12/31/2022	212	-1,748	-181	-157	N/A
9/30/2022	210	-1,757	-152	-118	N/A
6/30/2022	221	-1,718	-142	-110	N/A
3/31/2022	226	-1,233	-98	-64	N/A
12/31/2021	231	-381	-122	-82	N/A
9/30/2021	238	-607	-165	-124	N/A
6/30/2021	245	-692	-264	-211	N/A
3/31/2021	257	-2,387	-357	-284	N/A
12/31/2020	275	-2,359	-430	-285	N/A
9/30/2020	263	-3,342	-614	-357	N/A
6/30/2020	269	-3,231	-691	-342	N/A
3/31/2020	299	-1,405	-778	-293	N/A
12/31/2019	291	-1,430	-787	-289	N/A
9/30/2019	290	-385	-667	-218	N/A
6/30/2019	246	-294	-606	-192	N/A
3/31/2019	168	-211	-519	-233	N/A
12/31/2018	119	-72	-439	-206	N/A
9/30/2018	77	174	-334	-146	N/A
6/30/2018	55	72	N/A	-82	N/A
3/31/2018	42	-13	N/A	-35	N/A
12/31/2017	31	7	N/A	-16	N/A
9/30/2017	23	-4	N/A	-15	N/A
6/30/2017	18	-13	N/A	-13	N/A
3/31/2017	13	-16	N/A	-17	N/A
12/31/2016	8	-13	N/A	-11	N/A
9/30/2016	5	-10	N/A	-9	N/A
6/30/2016	1	-6	N/A	-7	N/A
3/31/2016	0	0	N/A	-5	N/A
12/31/2015	N/A	-3	N/A	-3	N/A
9/30/2015	N/A	-10	N/A	-3	N/A
6/30/2015	N/A	-10	N/A	-3	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ACB今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: ACB今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: ACB今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: ACBの収益 ( 11.8% ) Canadian市場 ( 7% ) よりも速いペースで成長すると予測されています。

高い収益成長: ACBの収益 ( 11.8% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ACBの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Aurora Cannabis 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Consensus estimates of losses per share improve by 75%

Forecast to breakeven in 2026

Price target increased by 13% to CA$9.92

Consensus EPS estimates fall by 29%, revenue upgraded

Price target decreased by 13% to CA$8.43

Consensus EPS estimates fall by 550%

Recent updates

Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump

Aurora Cannabis Inc. Expands Innovative Recreational Product Portfolio

Consensus estimates of losses per share improve by 75%

New minor risk - Profitability

Forecast to breakeven in 2026

Aurora Cannabis Inc. Announces Notice of Proposed Settlement of Class Action Involving All Persons and Entities Who Purchased Aurora Cannabis Inc. Common Stock Between October 23, 2018 and February 28, 2020, Inclusive

Second quarter 2025 earnings released: EPS: CA$0.05 (vs CA$0.048 in 2Q 2024)

Aurora Cannabis Inc. to Report Q2, 2025 Results on Nov 06, 2024

Aurora Cannabis Inc. Announces Board Changes and Changes to Board Committee Compositions

Price target increased by 13% to CA$9.92

Consensus EPS estimates fall by 29%, revenue upgraded

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

It's Unlikely That Aurora Cannabis Inc.'s (TSE:ACB) CEO Will See A Huge Pay Rise This Year

Aurora Cannabis Inc. to Report Q1, 2025 Results on Aug 07, 2024

Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump

Price target decreased by 13% to CA$8.43

Consensus EPS estimates fall by 550%

Full year 2024 earnings released: CA$1.28 loss per share (vs CA$8.22 loss in FY 2023)

Forecast breakeven date pushed back to 2027

Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors

Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products

New minor risk - Share price stability

Consensus EPS estimates upgraded to CA$1.44 loss

Price target increased by 62% to CA$16.58

Aurora Cannabis Inc. Announces CFO Changes

Why Aurora Cannabis' (TSE:ACB) Earnings Are Weaker Than They Seem

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Shareholder dilution

New minor risk - Profitability

Consensus EPS estimates fall by 48%, revenue upgraded

Aurora Cannabis Inc. (TSX:ACB) acquired remaining 90% stake in Indica Industries Pty Ltd for AUD 45 million.

Aurora Cannabis Inc. Provides Earnings Guidance for the Fourth Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q3, 2024 Results on Feb 08, 2024

Forecast to breakeven in 2026

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for Third Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q2, 2024 Results on Nov 09, 2023

New major risk - Shareholder dilution

Insider exercised options and sold CA$62k worth of stock

Aurora Cannabis Inc. has completed a Follow-on Equity Offering in the amount of CAD 38.826875 million.

Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?

Price target decreased by 27% to CA$0.96

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024

Aurora Cannabis Inc. to Report Q1, 2024 Results on Aug 10, 2023

Bevo Farms Ltd acquired Medicine Hat, Alberta Aurora Sun Facility from Aurora Cannabis Inc. (TSX:ACB) for CAD 15 million.

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

CEO & Director recently bought CA$131k worth of stock

New minor risk - Profitability

Consensus EPS estimates upgraded to CA$0.16 loss, revenue downgraded

Price target decreased by 20% to CA$1.49

Price target decreased by 10% to CA$1.75

Investors Holding Back On Aurora Cannabis Inc. (TSE:ACB)

Aurora Cannabis Inc. to Report Fiscal Year 2023 Results on Jun 14, 2023

Aurora Celebrates Summer with New Innovation Launching Across Canada

Aurora Cannabis Inc., Annual General Meeting, Aug 14, 2023

Forecast to breakeven in 2026

Aurora Cannabis Inc. Reports Impairment Changes for the Quarter Ended December 31, 2022

Price target decreased by 10% to CA$2.05

Second quarter 2023 earnings released

Aurora Cannabis Inc. to Report Q2, 2023 Results on Feb 09, 2023

Is Aurora Cannabis (TSE:ACB) Using Debt Sensibly?

An Unknown buyer acquired Aurora Polaris facility from Aurora Cannabis Inc. for CAD15 million.

Now 22% undervalued after recent price drop

Consensus revenue estimates fall by 14%

Forecast to breakeven in 2025

Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term

First quarter 2023 earnings released: CA$0.17 loss per share (vs CA$0.06 loss in 1Q 2022)